Multi-cancer early detection (MCED) tests are?tests that measure biological signals in body fluids that may be shed by cancer cells. These signals are also known as biomarkers or tumor markers. MCED tests are being developed to screen for cancers from more than one organ site at the same time.
This report contains market size and forecasts of Multi Cancer Early Detection in Global, including the following market information:
Global Multi Cancer Early Detection Market Revenue, 2018-2023, 2023-2030, ($ millions)
Global top five companies in 2022 (%)
The global Multi Cancer Early Detection market was valued at US$ million in 2022 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period 2023-2030.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million by 2030.
Liquid Biopsy Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Multi Cancer Early Detection include Grail, LLC (Illumina, Inc.), Exact Sciences Corporation., Foundation Medicine, Inc., AnchorDx, Guardant Health, Inc., Burning Rock Biotech Limited, GENECAST, Laboratory for Advanced Medicine, Inc. and Singlera Genomics Inc., etc. In 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Multi Cancer Early Detection companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Multi Cancer Early Detection Market, by Type, 2018-2023, 2023-2030 ($ millions)
Global Multi Cancer Early Detection Market Segment Percentages, by Type, 2022 (%)
Liquid Biopsy
Gene Panel, LDT & Others
Global Multi Cancer Early Detection Market, by Application, 2018-2023, 2023-2030 ($ millions)
Global Multi Cancer Early Detection Market Segment Percentages, by Application, 2022 (%)
Hospitals
Diagnostic Laboratories
Others
Global Multi Cancer Early Detection Market, By Region and Country, 2018-2023, 2023-2030 ($ Millions)
Global Multi Cancer Early Detection Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Multi Cancer Early Detection revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Multi Cancer Early Detection revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Grail, LLC (Illumina, Inc.)
Exact Sciences Corporation.
Foundation Medicine, Inc.
AnchorDx
Guardant Health, Inc.
Burning Rock Biotech Limited
GENECAST
Laboratory for Advanced Medicine, Inc.
Singlera Genomics Inc.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Multi Cancer Early Detection Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Multi Cancer Early Detection Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Multi Cancer Early Detection Overall Market Size
2.1 Global Multi Cancer Early Detection Market Size: 2022 VS 2030
2.2 Global Multi Cancer Early Detection Market Size, Prospects & Forecasts: 2018-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Multi Cancer Early Detection Players in Global Market
3.2 Top Global Multi Cancer Early Detection Companies Ranked by Revenue
3.3 Global Multi Cancer Early Detection Revenue by Companies
3.4 Top 3 and Top 5 Multi Cancer Early Detection Companies in Global Market, by Revenue in 2022
3.5 Global Companies Multi Cancer Early Detection Product Type
3.6 Tier 1, Tier 2 and Tier 3 Multi Cancer Early Detection Players in Global Market
3.6.1 List of Global Tier 1 Multi Cancer Early Detection Companies
3.6.2 List of Global Tier 2 and Tier 3 Multi Cancer Early Detection Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Multi Cancer Early Detection Market Size Markets, 2022 & 2030
4.1.2 Liquid Biopsy
4.1.3 Gene Panel, LDT & Others
4.2 By Type - Global Multi Cancer Early Detection Revenue & Forecasts
4.2.1 By Type - Global Multi Cancer Early Detection Revenue, 2018-2023
4.2.2 By Type - Global Multi Cancer Early Detection Revenue, 2023-2030
4.2.3 By Type - Global Multi Cancer Early Detection Revenue Market Share, 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Multi Cancer Early Detection Market Size, 2022 & 2030
5.1.2 Hospitals
5.1.3 Diagnostic Laboratories
5.1.4 Others
5.2 By Application - Global Multi Cancer Early Detection Revenue & Forecasts
5.2.1 By Application - Global Multi Cancer Early Detection Revenue, 2018-2023
5.2.2 By Application - Global Multi Cancer Early Detection Revenue, 2023-2030
5.2.3 By Application - Global Multi Cancer Early Detection Revenue Market Share, 2018-2030
6 Sights by Region
6.1 By Region - Global Multi Cancer Early Detection Market Size, 2022 & 2030
6.2 By Region - Global Multi Cancer Early Detection Revenue & Forecasts
6.2.1 By Region - Global Multi Cancer Early Detection Revenue, 2018-2023
6.2.2 By Region - Global Multi Cancer Early Detection Revenue, 2023-2030
6.2.3 By Region - Global Multi Cancer Early Detection Revenue Market Share, 2018-2030
6.3 North America
6.3.1 By Country - North America Multi Cancer Early Detection Revenue, 2018-2030
6.3.2 US Multi Cancer Early Detection Market Size, 2018-2030
6.3.3 Canada Multi Cancer Early Detection Market Size, 2018-2030
6.3.4 Mexico Multi Cancer Early Detection Market Size, 2018-2030
6.4 Europe
6.4.1 By Country - Europe Multi Cancer Early Detection Revenue, 2018-2030
6.4.2 Germany Multi Cancer Early Detection Market Size, 2018-2030
6.4.3 France Multi Cancer Early Detection Market Size, 2018-2030
6.4.4 U.K. Multi Cancer Early Detection Market Size, 2018-2030
6.4.5 Italy Multi Cancer Early Detection Market Size, 2018-2030
6.4.6 Russia Multi Cancer Early Detection Market Size, 2018-2030
6.4.7 Nordic Countries Multi Cancer Early Detection Market Size, 2018-2030
6.4.8 Benelux Multi Cancer Early Detection Market Size, 2018-2030
6.5 Asia
6.5.1 By Region - Asia Multi Cancer Early Detection Revenue, 2018-2030
6.5.2 China Multi Cancer Early Detection Market Size, 2018-2030
6.5.3 Japan Multi Cancer Early Detection Market Size, 2018-2030
6.5.4 South Korea Multi Cancer Early Detection Market Size, 2018-2030
6.5.5 Southeast Asia Multi Cancer Early Detection Market Size, 2018-2030
6.5.6 India Multi Cancer Early Detection Market Size, 2018-2030
6.6 South America
6.6.1 By Country - South America Multi Cancer Early Detection Revenue, 2018-2030
6.6.2 Brazil Multi Cancer Early Detection Market Size, 2018-2030
6.6.3 Argentina Multi Cancer Early Detection Market Size, 2018-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Multi Cancer Early Detection Revenue, 2018-2030
6.7.2 Turkey Multi Cancer Early Detection Market Size, 2018-2030
6.7.3 Israel Multi Cancer Early Detection Market Size, 2018-2030
6.7.4 Saudi Arabia Multi Cancer Early Detection Market Size, 2018-2030
6.7.5 UAE Multi Cancer Early Detection Market Size, 2018-2030
7 Players Profiles
7.1 Grail, LLC (Illumina, Inc.)
7.1.1 Grail, LLC (Illumina, Inc.) Corporate Summary
7.1.2 Grail, LLC (Illumina, Inc.) Business Overview
7.1.3 Grail, LLC (Illumina, Inc.) Multi Cancer Early Detection Major Product Offerings
7.1.4 Grail, LLC (Illumina, Inc.) Multi Cancer Early Detection Revenue in Global Market (2018-2023)
7.1.5 Grail, LLC (Illumina, Inc.) Key News
7.2 Exact Sciences Corporation.
7.2.1 Exact Sciences Corporation. Corporate Summary
7.2.2 Exact Sciences Corporation. Business Overview
7.2.3 Exact Sciences Corporation. Multi Cancer Early Detection Major Product Offerings
7.2.4 Exact Sciences Corporation. Multi Cancer Early Detection Revenue in Global Market (2018-2023)
7.2.5 Exact Sciences Corporation. Key News
7.3 Foundation Medicine, Inc.
7.3.1 Foundation Medicine, Inc. Corporate Summary
7.3.2 Foundation Medicine, Inc. Business Overview
7.3.3 Foundation Medicine, Inc. Multi Cancer Early Detection Major Product Offerings
7.3.4 Foundation Medicine, Inc. Multi Cancer Early Detection Revenue in Global Market (2018-2023)
7.3.5 Foundation Medicine, Inc. Key News
7.4 AnchorDx
7.4.1 AnchorDx Corporate Summary
7.4.2 AnchorDx Business Overview
7.4.3 AnchorDx Multi Cancer Early Detection Major Product Offerings
7.4.4 AnchorDx Multi Cancer Early Detection Revenue in Global Market (2018-2023)
7.4.5 AnchorDx Key News
7.5 Guardant Health, Inc.
7.5.1 Guardant Health, Inc. Corporate Summary
7.5.2 Guardant Health, Inc. Business Overview
7.5.3 Guardant Health, Inc. Multi Cancer Early Detection Major Product Offerings
7.5.4 Guardant Health, Inc. Multi Cancer Early Detection Revenue in Global Market (2018-2023)
7.5.5 Guardant Health, Inc. Key News
7.6 Burning Rock Biotech Limited
7.6.1 Burning Rock Biotech Limited Corporate Summary
7.6.2 Burning Rock Biotech Limited Business Overview
7.6.3 Burning Rock Biotech Limited Multi Cancer Early Detection Major Product Offerings
7.6.4 Burning Rock Biotech Limited Multi Cancer Early Detection Revenue in Global Market (2018-2023)
7.6.5 Burning Rock Biotech Limited Key News
7.7 GENECAST
7.7.1 GENECAST Corporate Summary
7.7.2 GENECAST Business Overview
7.7.3 GENECAST Multi Cancer Early Detection Major Product Offerings
7.7.4 GENECAST Multi Cancer Early Detection Revenue in Global Market (2018-2023)
7.7.5 GENECAST Key News
7.8 Laboratory for Advanced Medicine, Inc.
7.8.1 Laboratory for Advanced Medicine, Inc. Corporate Summary
7.8.2 Laboratory for Advanced Medicine, Inc. Business Overview
7.8.3 Laboratory for Advanced Medicine, Inc. Multi Cancer Early Detection Major Product Offerings
7.8.4 Laboratory for Advanced Medicine, Inc. Multi Cancer Early Detection Revenue in Global Market (2018-2023)
7.8.5 Laboratory for Advanced Medicine, Inc. Key News
7.9 Singlera Genomics Inc.
7.9.1 Singlera Genomics Inc. Corporate Summary
7.9.2 Singlera Genomics Inc. Business Overview
7.9.3 Singlera Genomics Inc. Multi Cancer Early Detection Major Product Offerings
7.9.4 Singlera Genomics Inc. Multi Cancer Early Detection Revenue in Global Market (2018-2023)
7.9.5 Singlera Genomics Inc. Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Multi Cancer Early Detection Market Opportunities & Trends in Global Market
Table 2. Multi Cancer Early Detection Market Drivers in Global Market
Table 3. Multi Cancer Early Detection Market Restraints in Global Market
Table 4. Key Players of Multi Cancer Early Detection in Global Market
Table 5. Top Multi Cancer Early Detection Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Multi Cancer Early Detection Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Multi Cancer Early Detection Revenue Share by Companies, 2018-2023
Table 8. Global Companies Multi Cancer Early Detection Product Type
Table 9. List of Global Tier 1 Multi Cancer Early Detection Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Multi Cancer Early Detection Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Multi Cancer Early Detection Revenue, (US$, Mn), 2022 & 2030
Table 12. By Type - Multi Cancer Early Detection Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Multi Cancer Early Detection Revenue in Global (US$, Mn), 2023-2030
Table 14. By Application ? Global Multi Cancer Early Detection Revenue, (US$, Mn), 2022 & 2030
Table 15. By Application - Multi Cancer Early Detection Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Multi Cancer Early Detection Revenue in Global (US$, Mn), 2023-2030
Table 17. By Region ? Global Multi Cancer Early Detection Revenue, (US$, Mn), 2022 & 2030
Table 18. By Region - Global Multi Cancer Early Detection Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Multi Cancer Early Detection Revenue (US$, Mn), 2023-2030
Table 20. By Country - North America Multi Cancer Early Detection Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Multi Cancer Early Detection Revenue, (US$, Mn), 2023-2030
Table 22. By Country - Europe Multi Cancer Early Detection Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Multi Cancer Early Detection Revenue, (US$, Mn), 2023-2030
Table 24. By Region - Asia Multi Cancer Early Detection Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Multi Cancer Early Detection Revenue, (US$, Mn), 2023-2030
Table 26. By Country - South America Multi Cancer Early Detection Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Multi Cancer Early Detection Revenue, (US$, Mn), 2023-2030
Table 28. By Country - Middle East & Africa Multi Cancer Early Detection Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Multi Cancer Early Detection Revenue, (US$, Mn), 2023-2030
Table 30. Grail, LLC (Illumina, Inc.) Corporate Summary
Table 31. Grail, LLC (Illumina, Inc.) Multi Cancer Early Detection Product Offerings
Table 32. Grail, LLC (Illumina, Inc.) Multi Cancer Early Detection Revenue (US$, Mn), (2018-2023)
Table 33. Exact Sciences Corporation. Corporate Summary
Table 34. Exact Sciences Corporation. Multi Cancer Early Detection Product Offerings
Table 35. Exact Sciences Corporation. Multi Cancer Early Detection Revenue (US$, Mn), (2018-2023)
Table 36. Foundation Medicine, Inc. Corporate Summary
Table 37. Foundation Medicine, Inc. Multi Cancer Early Detection Product Offerings
Table 38. Foundation Medicine, Inc. Multi Cancer Early Detection Revenue (US$, Mn), (2018-2023)
Table 39. AnchorDx Corporate Summary
Table 40. AnchorDx Multi Cancer Early Detection Product Offerings
Table 41. AnchorDx Multi Cancer Early Detection Revenue (US$, Mn), (2018-2023)
Table 42. Guardant Health, Inc. Corporate Summary
Table 43. Guardant Health, Inc. Multi Cancer Early Detection Product Offerings
Table 44. Guardant Health, Inc. Multi Cancer Early Detection Revenue (US$, Mn), (2018-2023)
Table 45. Burning Rock Biotech Limited Corporate Summary
Table 46. Burning Rock Biotech Limited Multi Cancer Early Detection Product Offerings
Table 47. Burning Rock Biotech Limited Multi Cancer Early Detection Revenue (US$, Mn), (2018-2023)
Table 48. GENECAST Corporate Summary
Table 49. GENECAST Multi Cancer Early Detection Product Offerings
Table 50. GENECAST Multi Cancer Early Detection Revenue (US$, Mn), (2018-2023)
Table 51. Laboratory for Advanced Medicine, Inc. Corporate Summary
Table 52. Laboratory for Advanced Medicine, Inc. Multi Cancer Early Detection Product Offerings
Table 53. Laboratory for Advanced Medicine, Inc. Multi Cancer Early Detection Revenue (US$, Mn), (2018-2023)
Table 54. Singlera Genomics Inc. Corporate Summary
Table 55. Singlera Genomics Inc. Multi Cancer Early Detection Product Offerings
Table 56. Singlera Genomics Inc. Multi Cancer Early Detection Revenue (US$, Mn), (2018-2023)
List of Figures
Figure 1. Multi Cancer Early Detection Segment by Type in 2022
Figure 2. Multi Cancer Early Detection Segment by Application in 2022
Figure 3. Global Multi Cancer Early Detection Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Multi Cancer Early Detection Market Size: 2022 VS 2030 (US$, Mn)
Figure 6. Global Multi Cancer Early Detection Revenue, 2018-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Multi Cancer Early Detection Revenue in 2022
Figure 8. By Type - Global Multi Cancer Early Detection Revenue Market Share, 2018-2030
Figure 9. By Application - Global Multi Cancer Early Detection Revenue Market Share, 2018-2030
Figure 10. By Region - Global Multi Cancer Early Detection Revenue Market Share, 2018-2030
Figure 11. By Country - North America Multi Cancer Early Detection Revenue Market Share, 2018-2030
Figure 12. US Multi Cancer Early Detection Revenue, (US$, Mn), 2018-2030
Figure 13. Canada Multi Cancer Early Detection Revenue, (US$, Mn), 2018-2030
Figure 14. Mexico Multi Cancer Early Detection Revenue, (US$, Mn), 2018-2030
Figure 15. By Country - Europe Multi Cancer Early Detection Revenue Market Share, 2018-2030
Figure 16. Germany Multi Cancer Early Detection Revenue, (US$, Mn), 2018-2030
Figure 17. France Multi Cancer Early Detection Revenue, (US$, Mn), 2018-2030
Figure 18. U.K. Multi Cancer Early Detection Revenue, (US$, Mn), 2018-2030
Figure 19. Italy Multi Cancer Early Detection Revenue, (US$, Mn), 2018-2030
Figure 20. Russia Multi Cancer Early Detection Revenue, (US$, Mn), 2018-2030
Figure 21. Nordic Countries Multi Cancer Early Detection Revenue, (US$, Mn), 2018-2030
Figure 22. Benelux Multi Cancer Early Detection Revenue, (US$, Mn), 2018-2030
Figure 23. By Region - Asia Multi Cancer Early Detection Revenue Market Share, 2018-2030
Figure 24. China Multi Cancer Early Detection Revenue, (US$, Mn), 2018-2030
Figure 25. Japan Multi Cancer Early Detection Revenue, (US$, Mn), 2018-2030
Figure 26. South Korea Multi Cancer Early Detection Revenue, (US$, Mn), 2018-2030
Figure 27. Southeast Asia Multi Cancer Early Detection Revenue, (US$, Mn), 2018-2030
Figure 28. India Multi Cancer Early Detection Revenue, (US$, Mn), 2018-2030
Figure 29. By Country - South America Multi Cancer Early Detection Revenue Market Share, 2018-2030
Figure 30. Brazil Multi Cancer Early Detection Revenue, (US$, Mn), 2018-2030
Figure 31. Argentina Multi Cancer Early Detection Revenue, (US$, Mn), 2018-2030
Figure 32. By Country - Middle East & Africa Multi Cancer Early Detection Revenue Market Share, 2018-2030
Figure 33. Turkey Multi Cancer Early Detection Revenue, (US$, Mn), 2018-2030
Figure 34. Israel Multi Cancer Early Detection Revenue, (US$, Mn), 2018-2030
Figure 35. Saudi Arabia Multi Cancer Early Detection Revenue, (US$, Mn), 2018-2030
Figure 36. UAE Multi Cancer Early Detection Revenue, (US$, Mn), 2018-2030
Figure 37. Grail, LLC (Illumina, Inc.) Multi Cancer Early Detection Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 38. Exact Sciences Corporation. Multi Cancer Early Detection Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 39. Foundation Medicine, Inc. Multi Cancer Early Detection Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 40. AnchorDx Multi Cancer Early Detection Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 41. Guardant Health, Inc. Multi Cancer Early Detection Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Burning Rock Biotech Limited Multi Cancer Early Detection Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. GENECAST Multi Cancer Early Detection Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Laboratory for Advanced Medicine, Inc. Multi Cancer Early Detection Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Singlera Genomics Inc. Multi Cancer Early Detection Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
